Aller au contenu principal
Accès ouvert déclaré 2026 article

Rutin as an alternative to Paracetamol: Evidence from behavioral, cellular, and inflammatory acute pain responses

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : in. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: Pain management following acute injury or postoperative procedures is necessary for appropriate recovery and quality of life. Opioids and non-steroidal anti-inflammatory drugs (NSAIDS) have been used for this purpose for an extended period; however, opioids cause addiction and withdrawal symptoms that require additional treatment, whereas NSAIDS have several systemic toxicities. The plant-derived flavonoid rutin has shown promising effects in reducing oxidative stress and inflammation. In this study, our primary objectives are to investigate the antinociceptive and anti-inflammatory effects of rutin as an alternative analgesic with limited adverse effects. Methods: Orally administered rutin and its antinociceptive effects were evaluated in a formalin-induced acute pain model in Swiss albino mice. Additionally, the antioxidant and anti-inflammatory effects of rutin were analyzed as preventive and therapeutic strategies in a formalin-induced acute pain model. Results: Decreased tail-flick and paw-withdrawal latencies were reversed by preventive and therapeutic Rutin treatment. Rutin treatment depleted reduced glutathione (GSH), reduced catalase and superoxide dismutase 1 (SOD1) activities, and elevated lipid peroxidation at the local level. The levels of the local neuroinflammatory mediator substance P (SP), calcitonin gene-related peptide (CGRP), neurokinin-1 receptor (NK1R), and p65 significantly decreased after Rutin treatment. Conclusion: The present evidence shows that rutin is not merely an analgesic but also a comprehensive neuroprotective and anti-neuroinflammatory agent. It corrects the underlying biochemical and cellular pathology that remained unexplored, reiterating the therapeutic efficacy and novelty that fundamentally eclipse the symptomatic relief offered by Paracetamol.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Rutin as an alternative to Paracetamol: Evidence from behavioral, cellular, and inflammatory acute pain responses
Date Crossref
30/03/2026
Éditeur
The Physiological Society of India
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pain Mechanisms and TreatmentsPain Management and Opioid UseCancer, Stress, Anesthesia, and Immune Response

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.